The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAcer Gdr Reg S Regulatory News (ACID)

Share Price Information for Acer Gdr Reg S (ACID)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.00
Bid: 8.00
Ask: 0.00
Change: -0.05 (-0.62%)
Spread: -8.00 (-100.00%)
Open: 8.00
High: 8.00
Low: 8.00
Prev. Close: 8.05
ACID Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

To announce the Company's information

11 Apr 2019 08:51

RNS Number : 8903V
Acer Incorporated
11 April 2019
 

Subject: Explanation about the Company's shareholders who are qualified to subscribe the new shares issued by Acer Synergy Tech Corporation's capital increase in cash

Contents:

1. Date of occurrence of the event: 2019/04/11

2. Company name: Acer Inc.

3. Relationship to the Company (please enter "head office" or "subsidiaries"): head office

4. Reciprocal shareholding ratios: NA

5. Cause of occurrence:

Explanation about the Company's shareholders who are qualified to subscribe the new shares

issued by Acer Synergy Tech Corporation's capital increase in cash:

a. The Company's subsidiary, Acer Synergy Tech Corporation (non-public, hereinafter "AST"), per the resolution of its board of directors meeting dated March 20, 2019, intends issue 3,500,000 common shares (hereinafter "AST new common shares") by capital increased in cash in 2019. The AST new common shares will be issued at NT$22 per share, and it is expected to acquire NT$77 million to enrich capital for AST's operation and business. Pursuant to the Article 267 of Company Act, 15% of the AST new common shares, i.e. 525,000 common shares, will be reserved for the employees of AST with preemptive subscription; and the remaining 85% of the AST new common shares, i.e. 2,975,000 common shares, will be reserved for the original shareholders of AST based on the list of shareholders roster on the dividend record date. Since the Company has held 91.74% of the shares of AST, the Company will be able to subscribe 2,729,356 common shares from the AST new common shares.

b. According to the resolution of 2018 General Shareholders' meeting, the Company intends to waive subscription from the AST new common shares that the Company may subscribed with 2,729,356 shares. And the Company's shareholders qualified to subscribe 1,000 shares or more of AST new common shares are shareholders who hold 1,126,616 shares or more of the Company as recorded in the Company's shareholders register on the book closure date (April 16, 2019).

c. In case the original shareholders of the Company subscribe less than 1,000 shares of AST new common shares or waive the rights of subscription, the Chairman of AST is authorized to negotiate with designated individuals to sell the AST new common shares at issuing price.

6. Countermeasures: None

7. Any other matters that need to be specified:

a. According to the schedule of new shares issuance by capital increased in cash, AST will send notices to the Company's qualified shareholders for payment of subscription of AST's new shares. Qualified shareholders who are willing to subscribe please make payment for the subscription within the period as stated in the subscription notice.

b. The Company's latest book closure date is April 16, 2019 and the last buying date is April 11, 2019. Within five days after the book closure date (i.e., April 16, 2019 to April 20, 2019), shareholders may apply to the Company's stock affairs office for combination of their shares. Shareholders not applying for combination within the period or whose combined shares are less than 1,126,616 shares are still not qualified to subscribe the AST new common shares.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCDFLBFKZFEBBB
Date   Source Headline
8th Nov 20228:50 amRNSTo announce the Company's information
3rd Nov 202210:04 amRNSTo announce the Company's information
7th Oct 202210:13 amRNSUn-Audited Monthly Sales Ended Sept 30, 2022
28th Sep 202210:09 amRNSTo announce the Company's information
19th Sep 202210:26 amRNSTo announce the Company's information
8th Sep 202210:36 amRNSUn-Audited Monthly Sales Ended Aug 31, 2022
1st Sep 20229:40 amRNSTo announce the Company's information
26th Aug 20229:04 amRNSTo announce the Company's information
9th Aug 202210:08 amRNSUn-Audited Monthly Sales Ended July 31, 2022
4th Aug 202210:14 amRNSTo announce the Company's information
8th Jul 202210:47 amRNSUn-Audited Monthly Sales Ended June 30, 2022
10th Jun 202210:51 amRNSTo announce the Company's information
10th Jun 20227:08 amRNSUn-Audited Monthly Sales Ended May 31, 2022
16th May 202210:16 amRNSTo announce the Company's information
10th May 202210:40 amRNSUn-Audited Monthly Sales Ended April 30, 2022
5th May 202210:12 amRNSTo announce the Company's information
29th Apr 202212:35 pmRNSTo announce the Company's information
8th Apr 20229:45 amRNSUn-Audited Monthly Sales Ended March 31, 2022
17th Mar 20229:18 amRNSTo announce the Company's information
16th Mar 202210:38 amRNSTo announce the Company's information
8th Mar 20229:10 amRNSUn-Audited Monthly Sales Ended February 28, 2022
24th Feb 20227:52 amRNSTo announce the Company's information
10th Feb 20229:58 amRNSUn-Audited Monthly Sales Ended Jan. 31, 2022
7th Jan 202210:59 amRNSUn-Audited Monthly Sales Ended Dec. 31, 2021
4th Jan 20229:43 amRNSTo announce the Company's information
8th Dec 20219:32 amRNSUn-Audited Monthly Sales Ended Nov. 30, 2021
19th Nov 20219:06 amRNSTo announce the Company's information
8th Nov 202110:04 amRNSUn-Audited Monthly Sales Ended Oct. 31, 2021
3rd Nov 202111:20 amRNSTo announce the Company's information
2nd Nov 20219:21 amRNSTo announce the Company's information
1st Nov 20219:23 amRNSTo announce the Company's information
19th Oct 202110:47 amRNSTo announce the Company's information
8th Oct 202110:20 amRNSUn-Audited Monthly Sales Ended Sept. 30, 2021
24th Sep 202110:39 amRNSTo announce the Company's information
8th Sep 202111:01 amRNSUn-Audited Monthly Sales Ended Aug. 31, 2021
17th Aug 202111:20 amRNSTo announce the Company's information
13th Aug 202110:53 amRNSTo announce the Company's information
9th Aug 202110:25 amRNSUn-Audited Monthly Sales Ended July 31, 2021
4th Aug 202110:37 amRNSTo announce the Company's information
27th Jul 20217:00 amRNSTo announce the Company's information
14th Jul 202111:31 amRNSTo announce the Company's information
12th Jul 202110:20 amRNSTo announce the Company's information
9th Jul 202110:09 amRNSTo announce the Company's information
8th Jul 202111:37 amRNSUn-Audited Monthly Sales Ended June 30, 2021
25th Jun 202110:15 amRNSTo announce the Company's information
9th Jun 202111:07 amRNSUn-Audited Monthly Sales Ended May 31, 2021
28th May 202111:51 amRNSTo announce the Company's information
21st May 20219:23 amRNSTo announce the Company's information
12th May 202111:24 amRNSTo announce the Company's information
10th May 202111:54 amRNSUn-Audited Monthly Sales Ended April 30, 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.